Health-Seeking Behavior Returning to Normalcy Overcoming COVID-19 Threat in Breast Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The coronavirus disease 2019 (COVID-19) outbreak has significantly impacted the diagnosis and treatment of breast cancer. Our study investigated the change in diagnosis and treatment of breast cancer with the progress of COVID-19 pandemic. Materials and Methods The study group comprised 6,514 recently diagnosed breast cancer patients between January 1, 2019, and February 28, 2021. The patients were divided into two groups: pre–COVID-19 period (3,182; January 2019 to December 2019) and COVID-19 pandemic period (3,332; January 2020 to February 2021). Clinicopathological information related to the first treatment after breast cancer diagnosis was retrospectively collected and analyzed in the two groups. Results Among the 6,514 breast cancer patients, 3,182 were in the pre–COVID-19 period and 3,332 were in the COVID-19 pandemic period. According to our evaluation, the least breast cancer diagnosis (21.8%) was seen in the first quarter of 2020. The diagnosis increased gradually except for the fourth quarter in 2020. While early-stage breast cancer was diagnosed 1,601 (48.1%) during the COVID-19 pandemic (p=0.001), the number of surgical treatments increased 4.6% (p < 0.001), and the treatment time was slightly shorter 2 days (p=0.001). The breast cancer subtype distribution was not statistically different between the pre–COVID-19 and COVID-19 period groups. Conclusion In the early stages of the pandemic, the number of breast cancer cases temporarily decreased; however, they stabilized soon, and no significant differences could be identified in the diagnosis and treatment when compared to the period before the pandemic.
Abstract
Purpose The coronavirus disease 2019 (COVID-19) outbreak has significantly impacted the diagnosis and treatment of breast cancer. Our study investigated the change in diagnosis and treatment of breast cancer with the progress of COVID-19 pandemic. Materials and Methods The study group comprised 6,514 recently diagnosed breast cancer patients between January 1, 2019, and February 28, 2021. The patients were divided into two groups: pre–COVID-19 period (3,182; January 2019 to December 2019) and COVID-19 pandemic period (3,332; January 2020 to February 2021). Clinicopathological information related to the first treatment after breast cancer diagnosis was retrospectively collected and analyzed in the two groups. Results Among the 6,514 breast cancer patients, 3,182 were in the pre–COVID-19 period and 3,332 were in the COVID-19 pandemic period. According to our evaluation, the least breast cancer diagnosis (21.8%) was seen in the first quarter of 2020. The diagnosis increased gradually except for the fourth quarter in 2020. While early-stage breast cancer was diagnosed 1,601 (48.1%) during the COVID-19 pandemic (p=0.001), the number of surgical treatments increased 4.6% (p < 0.001), and the treatment time was slightly shorter 2 days (p=0.001). The breast cancer subtype distribution was not statistically different between the pre–COVID-19 and COVID-19 period groups. Conclusion In the early stages of the pandemic, the number of breast cancer cases temporarily decreased; however, they stabilized soon, and no significant differences could be identified in the diagnosis and treatment when compared to the period before the pandemic.
참고문헌 (20)
- Emanuel EJ, "Fair allocation of scarce medical resources in the time of COVID-19", N Engl J Med, 382, pp.2049~2055 (2020)
- Burki TK, "Cancer guidelines during the COVID-19 pandemic", Lancet Oncol, 21, pp.629~630 (2020)
- Hanna TP, "Cancer, COVID-19 and the precautionary principle : prioritizing treatment during a global pandemic", Nat Rev Clin Oncol, 17, pp.268~270 (2020)
- De Vincentiis L, "Cancer diagnostic rates during the 2020 ‘lockdown’, due to COVID-19 pandemic, compared with the 2018-2019 : an audit study from cellular pathology", J Clin Pathol, 74, pp.187~189 (2021)
- Jacob L, "Impact of the COVID-19 pandemic on cancer diagnoses in general and specialized practices in Germany", Cancers(Basel), 13, pp.408~ (2021)
- Kaufman HW, "Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019(COVID-19)pandemic", JAMA Netw Open, 3, pp.e2017267~ (2020)
- Mahase E, "COVID-19 : urgent cancer referrals fall by 60%, showing"brutal"impact of pandemic", BMJ, 369, pp.m2386~ (2020)
- Zadnik V, "Impact of COVID-19 on cancer diagnosis and management in Slovenia : preliminary results", Radiol Oncol, 54, pp.329~334 (2020)
- Dighe A, "Response to COVID-19 in South Korea and implications for lifting stringent interventions", BMC Med, 18, pp.321~ (2020)
- 이기쁨, "Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea", Cancer Research and Treatment, 53(2), pp.323~329 (2021), 대한암학회[DOI]
- de Azambuja E, "ESMO management and treatment adapted recommendations in the COVID-19 era : Breast Cancer", ESMO Open, 5, pp.e000793~ (2020)
- "Cancer screening, diagnosis, staging and surveillance" (2020)[URL]
- "2020 Cancer statistics" (2022)[URL]
- 강영준, "Impact of the COVID-19 Pandemic on the Diagnosis and Surgery of Breast Cancer: A Multi-Institutional Study", Journal of Breast Cancer, 24(6), pp.491~503 (2021), 한국유방암학회[DOI]
- Li J, "Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China : a national survey of 8397 patients in the first quarter of 2020", EClinicalMedicine, 26, pp.100503~ (2020)
- Vanni G, "Breast cancer and COVID-19 : the effect of fear on patients’ decision-making process", In Vivo, 34, pp.1651~1659 (2020)
- Ilgun AS, "The impact of the COVID-19 pandemic on breast cancer patients", Eur J Breast Health, 18, pp.85~90 (2022)
- Borsky K, "Pattern of breast cancer presentation during the COVID-19 pandemic : results from a cohort study in the UK", Future Oncol, 18, pp.437~443 (2022)
- Creech CB, "SARS-CoV-2 vaccines", JAMA, 325, pp.1318~1320 (2021)
- Lee J, "Patterns of delaying surgery for breast cancer during the COVID-19 outbreak in Daegu, South Korea", Front Surg, 7, pp.576196~ (2020)